上海市浦东新区肾脏病专业委员会委员The member of Committee of Nephrology in Shanghai Pudong New Area美国肾脏病杂志中国版编委Chinese Edition of Journal of the American Society of Nephrology(JASN)
1.科研项目：第一负责人主持完成上海市浦东新区社发局课题一项，第一负责人主持上海市科委课题一项；主要参与者参加完成多项国家自然科学基金，上海市科委和上海市浦东新区科委项目。
The first person in charge presided over the completion of the the grant from the Social Development Bureau of Pudong New Area in Shanghai. The first person in charge presiding the grant from the Science and Technology Commission of Pudong New Area in Shanghai.The Key participants participated the grant from the National Natural Science Foundation of China, the Social Development Bureau of Pudong New Area in Shanghai and the Science and Technology Commission of Pudong New Area in Shanghai
2.发表文章如下：
The articles published are as follows:
（1）Liu Feng,Wang, Li,Qi Hualin,Wang Jun,Wang Yi,Jiang Wei,Xu Liuqing,Liu Na,Zhuang Shougang*,Nintedanib, a triple tyrosine kinase inhibitor, attenuates renal fibrosis in chronic kidney disease,Clin. Sci. 2017,131(16):2125-2143
（2）Liu Feng, Zong Ming, Wen Xiaofei, Li Xuezhu, Wang Jun, Wang Yi, Jiang Wei, Li Xiaojun, Guo Zhongliang, Qi Hualin*,Silencing of Histone Deacetylase 9 Expression in Podocytes Attenuates Kidney Injury in Diabetic Nephropathy,Sci.Rep,2016:33676
（3）Feng Liu, Shougang Zhuang*,Role of receptor tyrosine kinase signaling in renal fibrosis.Int J Mol Sci.2016,17:972.
（4）Liu Feng, Mei Xiaobin, Zhang Yingying, Qi Hualin, Wang Jun, Wang Yi, Jiang Wei, Zhang Xintian, Yan Haidong, Zhuang Shougang*, Correlation of Peroxisome Proliferator-Activated ReceptorγGene Pro12Ala and C161T Polymorphisms with Cardiovascular Disease in Patients on Hemodialysis,Mol Biol Rep.2014,41:7555–7565
（5）Liu Feng, Zhang,Xintian Qi Hualin, Wang Jun, Wang Min, Zhang Yingying, Yan Haidong, Zhuang Shougang*,Correlation of serum magnesium with cardiovascular risk factors in maintenance hemodialysis patients--a cross-sectional study,Magnes Res,2013,26(3):100-108
（6）Zhu Yufei,Zhu Yunhai,Cai Feng,Zhao Jie,Liu Feng*,Prognostic Risk Factors Associated with Recurrence and Metastasis After Radical Resection in Patients with Hepatolithiasis Complicated by Intrahepatic Cholangiocarcinoma,Cell Biochemistry and Biophysics,2015, 73(2):455-460
（7）Wang Weiming,Liu Feng,Chen Nan*,Peroxisome Proliferator-Activated Receptor-γ (PPAR-γ) Agonists Attenuate the Profibrotic Response Induced by TGF-β1 in Renal Interstitial Fibroblasts, Mediators of Inflammation, 2007,10(7): 134~140
（8）刘峰,张颖莹,齐华林,张新天,王俊,江薇,庄守纲,王奕*, 过氧化物酶体增殖物激活受体γ Pro12Ala基因多态性与慢性肾脏病危险因素的关系, 新乡医学院学报,2014, 05: 328~332 .
（9）刘峰,张新天,齐华林,张瑞青,江薇,余晨,严海东*,过氧化物酶体增殖物激活受体γC161T基因多态性与慢性肾脏病的关系, 上海医学, 2009, 09: 779~782
（10）刘峰,王奕,陈迟,顾晓波,贾新颜,徐晓云,刘菲,严海东*,内科学专业住院医师规范化培训新模式的初步探索, 中国高等医学教育, 2012, (06): 48~49+67
（11） 刘玉夏,朱丽芹,张新天,刘峰*,铁调素对维持性血液透析患者铁稳态的影响, 齐鲁护理杂志, 2012, (16): 124~125
(12) 刘峰，陈佳韵，王伟铭，陈楠。过氧化物酶体增殖物活化受体γ激动剂对人肾间质成纤维细胞增殖及凋亡的影响。中华肾脏病杂志，2004，20：43－47。
（13）刘峰，王伟铭，陈楠。过氧化物酶体增殖物活化受体γ激动剂对对TGF-β1诱导肾成纤维细胞细胞外基质成份表达的影响。肾脏病与透析肾移植杂志,2006，15（1）：30－34。
（14）刘峰，陈楠。PPARγ的表达调节。中国生物学文摘，2004，18（9）：1－6。
（15）刘峰，陈楠。过氧化物酶体增殖物激活受体与肾脏病研究新进展。中国中西医结合肾病杂志，2005，6（1）：51－54。
（16）王伟铭，刘峰，陈楠。过氧化物酶体增殖物激活受体γ激动剂对大鼠肾成纤维细胞转化生长因子β1 /Smad信号途径的作用研究。中华医学杂志。2006,86:740-744.
（17） 齐华林, 刘峰, 王俊, 余晨, 严海东. 连续性肾脏替代治疗强度对急性肾衰患者预后影响的荟萃分析.中华肾脏病杂志. 2010,26(12):880-886.
